Medicare Advantage Population in the United States: Outcomes of Patients with Asthma Treated with ICS/LABA Before and After Initiation with Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI).
Saved in:
| Title: | Medicare Advantage Population in the United States: Outcomes of Patients with Asthma Treated with ICS/LABA Before and After Initiation with Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI). |
|---|---|
| Authors: | Baptist AP; Division of Allergy and Clinical Immunology, Henry Ford Health and MI State University Health Sciences, One Ford Place, 3A32, Detroit, MI, 48202, USA. abaptis1@hfhs.org., Germain G; Group d'Analyse, Ltée, Montreal, QC, Canada., Klimek J; Analysis Group, Inc, Boston, MA, USA., Laliberté F; Group d'Analyse, Ltée, Montreal, QC, Canada., Schell RC; Analysis Group, Inc, Menlo Park, CA, USA., Forero-Schwanhaeuser S; US Medical Affairs, GSK, Durham, NC, USA., Moore A; Global Medical Affairs, General Medicines, GSK, London, UK., Noorduyn SG; Value Evidence and Outcomes, R&D Global Medical, GSK, Mississauga, ON, Canada.; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada., Paczkowski R; US Value Evidence and Outcomes, GSK, Collegeville, PA, USA. |
| Source: | Advances in therapy [Adv Ther] 2025 Feb; Vol. 42 (2), pp. 1061-1074. Date of Electronic Publication: 2024 Dec 23. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1865-8652 |
|---|---|
| DOI: | 10.1007/s12325-024-03083-6 |
